INDP
Indaptus Therapeutics Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$1.77
-0.03 ▼ -1.67%
🌙 3월 13일 4:04 PM ET (한국 3/14 05:04)
$1.76
-0.01 ▼ -0.56%
| Index | - | P/E | - | EPS (ttm) | -31.51 | Insider Own | 36.43% | Shs Outstand | 0.00B | Perf Week | -4.32% |
| Market Cap | 0.00B | Forward P/E | - | EPS next Y | 69.5% | Insider Trans | - | Shs Float | 0.00B | Perf Month | -0.56% |
| Enterprise Value | -0.00B | PEG | - | EPS next Q | -4.36 | Inst Own | 4.09% | Short Float | 1.36% | Perf Quarter | -33.21% |
| Income | -0.02B | P/S | - | EPS this Y | 53.88% | Inst Trans | 8.62% | Short Ratio | 0.03 | Perf Half Y | -37.46% |
| Sales | 0.00B | P/B | 0.63 | EPS next 5Y | 53.89% | ROA | -223.71% | Short Interest | 0.02M | Perf YTD | -39.18% |
| Book/sh | 2.81 | P/C | 0.68 | EPS past 3/5Y | 5.21% 57.27% | ROE | -317.98% | 52W High | -96.28% ($47.60) | Perf Year | -92.16% |
| Cash/sh | 2.6 | P/FCF | - | Sales past 3/5Y | - | ROIC | -366.23% | 52W Low | 16.45% ($1.52) | Perf 3Y | -96.24% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 34.57% | Gross Margin | - | Volatility(W/M) | 9.41% 9.4% | Perf 5Y | -99.66% |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 0.19 | Perf 10Y | -99.98% |
| Dividend Ex-Date | - | Quick Ratio | 2.88 | EPS Q/Q | 66.98% | Profit Margin | - | RSI (14) | 40.69 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 2.88 | Sales Q/Q | - | SMA20 | -7.33% ($1.91) | Beta | 0.96 | Target Price | $10 |
| Payout | - | Debt/Eq | 0 | Earnings | 11000000 | SMA50 | -21.21% ($2.25) | Rel Volume | 0.02 | Prev Close | $1.8 |
| Employees | 7 | LT Debt/Eq | 0 | EPS/Sales Surpr. | 28.54% - | SMA200 | -64.01% ($4.92) | Avg Volume(3M) | 0.72M | Price | $1.77 |
| IPO | 2012/12/26 | Option/Short | No/Yes | Trades | 334 | Volume | 14,759 | Change | -1.67% |
뉴스 로딩 중...